# Lake Shore Bancorp, Inc.: overview LSBK · Nasdaq · CIK 2059653 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lsbk.md) · [Financials](/companies/lsbk/financials.md) · [Filings](/companies/lsbk/filings.md) · [Insiders](/companies/lsbk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.18](/filings/0001193125-25-277623.md) | not reported | [0.14](/filings/0001193125-26-219601.md) | [0.25](/filings/0001193125-26-344793.md) | [0.32](/filings/0001193125-25-277623.md) | not reported | [0.26](/filings/0001193125-26-219601.md) | [0.29](/filings/0001193125-26-344793.md) | | Free cash flow | $k | [(1,417) d](/filings/0001193125-25-277623.md) | not reported | [568](/filings/0001193125-26-219601.md) | [1,406 d](/filings/0001193125-26-344793.md) | [3,298 d](/filings/0001193125-25-277623.md) | not reported | [2,782](/filings/0001193125-26-219601.md) | [2,259 d](/filings/0001193125-26-344793.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | | Revenue | $ | not reported | not reported | | Gross margin | % | not reported | not reported | | Operating margin | % | not reported | not reported | | Net margin | % | not reported | not reported | | Diluted EPS | $ per share | [0.65](/filings/0001193125-26-109481.md) | [0.97](/filings/0001193125-26-109481.md) | | Free cash flow | $ | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lsbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [STILWELL VALUE LLC](/funds/1397076.md) | 2026-06-30 | $13.8m | 773,675 | | Unchanged | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $7.7m | 505,971 | | Added +57,012 | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $3.2m | 180,000 | | Unchanged | | [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $2.7m | 150,585 | | Unchanged | | [HBK Sorce Advisory LLC](/funds/1379995.md) | 2026-06-30 | $1.5m | 85,173 | | Reduced −2,905 | | [GRAHAM CAPITAL WEALTH MANAGEMENT, LLC](/funds/1907528.md) | 2026-06-30 | $1.3m | 74,543 | | Reduced −647 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $1.2m | 70,039 | | Added +1,096 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.2m | 65,641 | | Reduced −3,400 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $853.1k | 47,933 | | Added +2,224 | | [Minerva Advisors LLC](/funds/1541536.md) | 2026-06-30 | $788.3k | 44,259 | | Unchanged | ## Recent filings [All 86 filings](/companies/lsbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 08:30 ET | [8-K](/filings/0001193125-26-429503.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429503 | | 2026-10-21 | 20:30 ET | [8-K](/filings/0001193125-26-427891.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-427891 | | 2026-08-11 | 20:30 ET | [10-Q](/filings/0001193125-26-344793.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344793 | | 2026-07-24 | 12:30 ET | [8-K](/filings/0001193125-26-315200.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-315200 | | 2026-07-22 | 20:30 ET | [8-K](/filings/0001193125-26-312448.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-312448 | | 2026-05-20 | 20:30 ET | [8-K](/filings/0001193125-26-232690.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232690 | | 2026-05-20 | 12:30 ET | [8-K](/filings/0001193125-26-231802.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-231802 | | 2026-05-12 | 20:30 ET | [10-Q](/filings/0001193125-26-219601.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219601 | | 2026-04-24 | 20:30 ET | [8-K](/filings/0001193125-26-177398.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-177398 | | 2026-04-22 | 20:30 ET | [8-K](/filings/0001193125-26-170558.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-170558 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-109481.md), filed Mar 17, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 2059653 - Tickers: LSBK - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.